insights_auto
Istiqbol: 66.7% optimistik·3.0% pessimistik
Tahlilga kirishchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,46Â US$
arrow_downward
-1,36%(-0,020) 1K
12-noy, 9:42:56 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoINO tikeri uchun statistika yaratilmoqda...
Ochish
1,44Â US$
Yuqori
1,46Â US$
Past
1,33Â US$
Bozor kapitali
270,68Â mln
Oʻrtacha hajm
19,06Â mln
Hajmi
209,16Â ming
52 haftalik eng yuqori
2,72Â US$
52 haftalik eng past
0,56Â US$
Aksiya boʻyicha daromad
-1,17Â US$
Beta
1,71
Muomaladagi aksiyalar
187,31Â mln
Xodimlar soni
112
Ochish
1,44Â US$
Yuqori
1,46Â US$
Past
1,33Â US$
Bozor kapitali
270,68Â mln
Oʻrtacha hajm
19,06Â mln
Hajmi
209,16Â ming
52 haftalik eng yuqori
2,72Â US$
52 haftalik eng past
0,56Â US$
Aksiya boʻyicha daromad
-1,17Â US$
Beta
1,71
Muomaladagi aksiyalar
187,31Â mln
Xodimlar soni
112
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Yahoo Finance
·
3 soat oldin
Inovio Pharmaceuticals Inc (INO) (Q3 2026) Earnings Call Highlights: FDA Approval, Commercial ...
GuruFocus
·
23 soat oldin
INO Reiterated by Piper Sandler -- Price Target Lowered to $6.00
Yahoo Finance
·
1 kun oldin
Inovio Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
TradingView
·
1 kun oldin
Key facts: INO Extends Runway; 2027 Launch; Data, Partner Search
Profil
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Inovio Pharmaceuticals Inc haqida
CEOJacqueline Shea
Xodimlar soni112
Asos solingan1999
Bosh ofislar-
SektorHealth Care
Soha-
Veb-saytinovio.com